Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$92,012,220
-$68,847,061 QoQ
Shares Held
545,937
-55.3% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#34
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Jun 30, 2025CallValue
$1,558,556
CallShares
12,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in NBIX
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,012,220 | 545,937 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $160,859,281 | 1,221,036 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $139,493,774 | 983,528 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $51,178,616 | 364,572 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,558,556 | 12,400 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $75,681,090 | 602,125 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $86,876,409 | 785,501 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $57,251,921 | 419,428 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $41,429,538 | 359,569 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $43,631,337 | 316,927 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,497,536 | 235,626 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $18,959,471 | 143,894 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $15,101,887 | 134,239 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $11,627,283 | 123,301 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,614,642 | 124,626 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $25,894,352 | 216,798 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $16,156,663 | 152,120 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $8,168,530 | 83,797 | Shares | Defined | 2022-08-10 | |
| 2022-06-30 | $7,018,560 | 72,000 | Put | Defined | 2022-08-10 | |
| 2022-03-31 | $6,750,000 | 72,000 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $21,116,811 | 225,246 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,392,756 | 86,800 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $19,236,154 | 225,856 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,469,183 | 171,715 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $383,640 | 4,000 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $13,759,781 | 141,387 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,934,648 | 91,873 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,497,942 | 15,628 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,556,348 | 16,185 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,224,352 | 59,216 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $3,462,000 | 40,000 | Call | Defined | 2020-05-01 | |
| 2020-03-31 | $4,335,807 | 50,096 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||